Organization
Città della Salute e della Scienza
4 abstracts
Abstract
Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial.Org: Oncology Institute of Southern Switzerland, Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland, University of Southampton,
Abstract
Preoperative assessment in lung-limited metastatic patients with colorectal cancer: The Meta-Lung Score.Org: University Hospital and University of Cagliari, Division of Thoracic Surgery at “A. Businco Cancer Center”, Division of Thoracic Surgery, Brigham and Women's Hospital, Cardiovascular and Thoracic Department, Città della Salute e della Scienza,
Abstract
Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) randomized clinical trials (RCTs).Org: IRCCS Ospedale Policlinico San Martino, Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, UOC Oncologia Medica,
Abstract
Nine-weeks versus one-year trastuzumab for early-stage HER2+ breast cancer: 10-year update of the Short-HER phase III randomized trial.Org: University of Padua School of Medicine, Veneto Institute of Oncology IOV-IRCCS Padua, Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia, Department of Oncology, Hematology, and Respiratory Diseases, Modena University,